Clincosm LogoSign in Get a demo

Breast Cancer

Showing NaN - NaN of 420
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Houston (Sacituzumab Govitecan, Pembrolizumab)

Not yet recruiting
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Dec 22, 2022

Contrast-enhanced Mammography for Breast Cancer Screening and

Recruiting
  • Breast Cancer
  • Contrast Enhanced Mammography
  • Houston, Texas
    M D Anderson Cancer Center
Dec 28, 2022

Breast Cancer, Breast Tumors, Colon Cancer Trial in United States (AZD6244, Dacarbazine, Erlotinib)

Active, not recruiting
  • Breast Cancer
  • +7 more
  • Detroit, Michigan
  • +3 more
Dec 22, 2022

Breast Cancer Trial in Worldwide (Ribociclib, Letrozole or Anastrozole, Goserelin)

Active, not recruiting
  • Breast Cancer
  • Mobile, Alabama
  • +90 more
Dec 19, 2022

Breast Cancer Trial in Houston (Trastuzumab deruxtecan, Valemetostat)

Not yet recruiting
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Dec 14, 2022

Breast Cancer Trial in Houston (GEH121224 (18F) Injection, Dynamic and Static - PET/CT Scan, Static - PET/CT Scan)

Not yet recruiting
  • Breast Cancer
  • GEH121224 (18F) Injection
  • +2 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Centre
Dec 13, 2022

Breast Cancer Trial in Denver, Sarasota, Nashville (AC682)

Recruiting
  • Breast Cancer
  • Denver, Colorado
  • +4 more
Dec 12, 2022

HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer Trial in United States (Pertuzumab+TRASTUZUMAB,

Recruiting
  • HER2-positive Breast Cancer
  • +5 more
  • Pertuzumab+TRASTUZUMAB
  • ADJUVANT ENDOCRINE THERAPY
  • Stamford, Connecticut
  • +21 more
Dec 12, 2022

NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)

Completed
  • Non-small Cell Lung Cancer
  • +9 more
  • Little Rock, Arkansas
  • +32 more
Dec 12, 2022

Ovarian Cancer, Breast Cancer, Colorectal Cancer Trial in Houston (Genetic Testing and Counseling, Screening Form)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Genetic Testing and Counseling
  • Screening Form
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Breast Cancer Trial in Greece, Israel, United States (MammaPrint, BluePrint, and Full-Genome Testing)

Recruiting
  • Breast Cancer
  • MammaPrint, BluePrint, and Full-Genome Testing
  • Birmingham, Alabama
  • +117 more
Dec 1, 2022

Pancreatic Cancer, Breast Cancer, Hepatocellular Carcinoma Trial in Houston (Piflufolastat F18)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Piflufolastat F18
  • Houston, Texas
    MD Anderson Cancer Center
Nov 28, 2022

Breast Cancer Trial in Worldwide (Olaparib, Placebo)

Active, not recruiting
Has Results
  • Breast Cancer
  • Anchorage, Alabama
  • +698 more
Nov 25, 2022

Breast Cancer Trial in United States (Survey)

Active, not recruiting
Has Results
  • Breast Cancer
  • Survey
  • Boston, Massachusetts
  • +5 more
Nov 22, 2022

Breast Cancer Trial in United States (Photon, Proton)

Recruiting
  • Breast Cancer
  • Photon
  • Proton
  • Birmingham, Alabama
  • +40 more
Nov 18, 2022

Estrogen Receptor Positive Breast Cancer, Breast Cancer Trial in Houston (ESTRING, Replens)

Recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Breast Cancer
  • Houston, Texas
    Houston Methodist Cancer Center
Nov 18, 2022

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

Recruiting
  • Stage I Breast Cancer
  • +7 more
  • Baltimore, Maryland
  • +6 more
Nov 11, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • PY159 Single agent dose level 1
  • +17 more
  • San Francisco, California
  • +11 more
Nov 3, 2022

Breast Cancer, Cholangiocarcinoma, Ovarian Cancer Trial in Worldwide (AZD8205)

Recruiting
  • Breast Cancer
  • +3 more
  • Duarte, California
  • +12 more
Oct 31, 2022

Non-Invasive Magnetic Resonance Imaging and Magnetic Resonance

Completed
  • Breast Cancer
  • Magnetic Resonance Imaging (MRI)
  • Magnetic Resonance Spectroscopy (MRS)
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 27, 2022

Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer Trial in San Francisco, Denver, San Antonio (P-MUC1C-ALLO1 CAR-T

Recruiting
  • Breast Cancer
  • +8 more
  • San Francisco, California
  • +4 more
Oct 26, 2022

TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Breast Cancer
  • Birmingham, Alabama
  • +111 more
Oct 25, 2022

Breast Cancer, Tumor Metastasis Trial in Houston (Trastuzumab, RAD001)

Completed
Has Results
  • Breast Cancer
  • Neoplasm Metastasis
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 30, 2022